| Stock Price Performance - 12 Largest Positive Opening Gaps | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Day of Event |
After Event Date (Not Including Day of Selected Event) |
||||||||||||||||
| Date | Note | Day-Of Move | Opening Gap | % Open-to-High | % Open-to-Low | Drift Open-to-Close | 1 Day | 2 Days | 3 Days | 1 Week | 2 Weeks | ||||||
| 31-Mar-2026 | Market Gap UpSPY had a large positive gap on the day of +1.1% | +17.8% | |||||||||||||||
| 15-Dec-2025 |
Press Release Milestone Receives FDA Approval of CARDAMYST (etripamil) as First and Only Self-Administered Nasal Spray for Adults with Paroxysmal Supraventricular Tachycardia (PSVT) (12-Dec-2025, 8:00 PM Globe Newswire) |
-2.7% | |||||||||||||||
| 12-May-2025 | Market Gap UpSPY had a large positive gap on the day of +3.1% | +8.1% | |||||||||||||||
| 23-Apr-2025 | Market Gap UpSPY had a large positive gap on the day of +2.5% | +9.4% | |||||||||||||||
| 27-Mar-2025 | +11.9% | ||||||||||||||||
| 24-Mar-2025 | Market Gap UpSPY had a large positive gap on the day of +1.2% | +7.9% | |||||||||||||||
| 14-Mar-2025 |
Day After EarningsMIST released earnings 13-Mar-2025 BMOPress Release Milestone Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Regulatory and Corporate Update (13-Mar-2025, 7:08 AM Globe Newswire) HeadlineMilestone Pharmaceuticals GAAP EPS of -$0.19 (13-Mar-2025, 12:00 AM Seeking Alpha News) |
+6.9% | |||||||||||||||
| 8-Oct-2024 | +0.7% | ||||||||||||||||
| 9-Sep-2024 |
Press Release Milestone Partner Ji Xing Pharmaceuticals Ltd Announces Positive Topline Results from the Phase 3 Study of Etripamil in PSVT in China (6-Sep-2024, 7:00 AM Globe Newswire) |
-1.4% | |||||||||||||||
| 12-Jul-2024 | +3.3% | ||||||||||||||||
| 26-Feb-2024 |
Press Release Milestone Pharmaceuticals Announces Plan to Resubmit NDA for Etripamil for the Treatment of PSVT (26-Feb-2024, 7:00 AM Globe Newswire) |
+24.1% | |||||||||||||||
| 24-Aug-2023 | -1.0% | ||||||||||||||||
| Simple Average Returns - 12 Largest Positive Opening Gaps | |||||||||||||||||
| Avg Return | |||||||||||||||||
| Positive Occurrences | |||||||||||||||||
| Negative Occurrences | |||||||||||||||||
| Absolute Average Returns - 12 Largest Positive Opening Gaps | |||||||||||||||||
| Abs Avg Return | |||||||||||||||||
| Max Abs Return | |||||||||||||||||
| Min Abs Return | |||||||||||||||||
| Median, Minimum, and Maximum Returns - 12 Largest Positive Opening Gaps | |||||||||||||||||
| Median Return | |||||||||||||||||
| Max Positive Return | |||||||||||||||||
| Max Negative Return | |||||||||||||||||